Jielin Sun

8.8k total citations
94 papers, 3.0k citations indexed

About

Jielin Sun is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Jielin Sun has authored 94 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 42 papers in Genetics and 28 papers in Molecular Biology. Recurrent topics in Jielin Sun's work include Prostate Cancer Treatment and Research (42 papers), Genetic Associations and Epidemiology (32 papers) and Prostate Cancer Diagnosis and Treatment (23 papers). Jielin Sun is often cited by papers focused on Prostate Cancer Treatment and Research (42 papers), Genetic Associations and Epidemiology (32 papers) and Prostate Cancer Diagnosis and Treatment (23 papers). Jielin Sun collaborates with scholars based in United States, Sweden and China. Jielin Sun's co-authors include Jianfeng Xu, William B. Isaacs, S. Lilly Zheng, Henrik Grönberg, Seong‐Tae Kim, Aubrey R. Turner, Wennuan Liu, Siqun L. Zheng, Jianfeng Xu and Bao‐Li Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jielin Sun

92 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jielin Sun United States 36 1.3k 1.2k 930 775 369 94 3.0k
S. Lilly Zheng United States 36 1.3k 1.1× 1.3k 1.1× 946 1.0× 654 0.8× 534 1.4× 113 3.2k
Aubrey R. Turner United States 28 807 0.6× 1.0k 0.9× 529 0.6× 599 0.8× 300 0.8× 42 2.2k
Siqun L. Zheng United States 36 1.4k 1.1× 1.4k 1.2× 1.2k 1.3× 724 0.9× 416 1.1× 79 3.9k
Bao‐Li Chang United States 28 794 0.6× 783 0.7× 589 0.6× 458 0.6× 227 0.6× 43 1.8k
Kimmo Savinainen Finland 16 743 0.6× 847 0.7× 343 0.4× 434 0.6× 307 0.8× 19 1.8k
Kathleen C. Torkko United States 29 916 0.7× 661 0.6× 438 0.5× 424 0.5× 900 2.4× 46 2.6k
Tuomas Mirtti Finland 29 1.1k 0.8× 1.6k 1.3× 275 0.3× 718 0.9× 825 2.2× 127 3.0k
Andrew Strahs United States 20 1.0k 0.8× 1.6k 1.4× 307 0.3× 750 1.0× 651 1.8× 52 2.8k
Toshiyuki Kamoto Japan 37 1.6k 1.3× 1.4k 1.2× 398 0.4× 602 0.8× 840 2.3× 262 3.9k
Koustubh Ranade United States 28 659 0.5× 818 0.7× 355 0.4× 679 0.9× 983 2.7× 63 3.2k

Countries citing papers authored by Jielin Sun

Since Specialization
Citations

This map shows the geographic impact of Jielin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jielin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jielin Sun more than expected).

Fields of papers citing papers by Jielin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jielin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jielin Sun. The network helps show where Jielin Sun may publish in the future.

Co-authorship network of co-authors of Jielin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jielin Sun. A scholar is included among the top collaborators of Jielin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jielin Sun. Jielin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Edwin C.Y., Alexei Ionan, Shwu‐Luan Lee, et al.. (2024). FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical Cancer Research. 30(19). 4266–4271. 2 indexed citations
2.
Woods, Ashley, Kelly J. Norsworthy, Jonathon Vallejo, et al.. (2023). FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical Cancer Research. 30(7). 1226–1231. 16 indexed citations
3.
Larkins, Erin, Pallavi S. Mishra‐Kalyani, Stephanie Aungst, et al.. (2023). FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical Cancer Research. 29(17). 3262–3266. 33 indexed citations
4.
Huang, Wei, Ying Wu, Jinxiu Shi, et al.. (2020). Variant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index. UNC Libraries. 1 indexed citations
5.
Jin, Guangfu, Jielin Sun, Seong‐Tae Kim, et al.. (2012). Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men. Human Molecular Genetics. 21(23). 5222–5228. 61 indexed citations
6.
Tao, Shasha, Zhong Wang, Junjie Feng, et al.. (2012). A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants. Carcinogenesis. 33(3). 598–603. 31 indexed citations
7.
Ma, Zhicheng, Qingfeng Hu, Zhuo Chen, et al.. (2012). Systematic evaluation of bladder cancer risk‐associated single‐nucleotide polymorphisms in a chinese population. Molecular Carcinogenesis. 52(11). 916–921. 39 indexed citations
8.
Feng, Junjie, Jielin Sun, Seong‐Tae Kim, et al.. (2011). A Genome-Wide Survey over the ChIP-On-Chip Identified Androgen Receptor-Binding Genomic Regions Identifies a Novel Prostate Cancer Susceptibility Locus at 12q13.13. Cancer Epidemiology Biomarkers & Prevention. 20(11). 2396–2403. 7 indexed citations
9.
Jin, Guangfu, Jielin Sun, Sarah D. Isaacs, et al.. (2011). Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 32(11). 1655–1659. 112 indexed citations
10.
Cheng, Yu, Wennuan Liu, Seong‐Tae Kim, et al.. (2011). Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Cancer Genetics. 204(7). 375–381. 52 indexed citations
11.
Hsu, Fang‐Chi, Jielin Sun, Yi Zhu, et al.. (2010). Comparison of Two Methods for Estimating Absolute Risk of Prostate Cancer Based on Single Nucleotide Polymorphisms and Family History. Cancer Epidemiology Biomarkers & Prevention. 19(4). 1083–1088. 14 indexed citations
12.
Feng, Junjie, Jielin Sun, Michael Zhuo Wang, et al.. (2010). Compilation of a Comprehensive Gene Panel for Systematic Assessment of Genes that Govern an Individual’s Drug Responses. Pharmacogenomics. 11(10). 1403–1425. 11 indexed citations
13.
Hsu, Fang‐Chi, Jielin Sun, Fredrik Wiklund, et al.. (2009). A Novel Prostate Cancer Susceptibility Locus at 19q13. Cancer Research. 69(7). 2720–2723. 36 indexed citations
14.
Liu, Wennuan, Jishan Sun, Ge Li, et al.. (2009). Association of a Germ-Line Copy Number Variation at 2p24.3 and Risk for Aggressive Prostate Cancer. Cancer Research. 69(6). 2176–2179. 58 indexed citations
15.
Kader, A. Karim, Jielin Sun, Helen Fedor, et al.. (2009). POD-02.10: Individual and Cumulative Effect of Prostate Cancer Risk-associated Variants on Clinicopathologic Variables in 5,895 Prostate Cancer Patients. Urology. 74(4). S7–S8. 1 indexed citations
16.
Sun, Jielin, Siqun L. Zheng, Fredrik Wiklund, et al.. (2008). Sequence Variants at 22q13 Are Associated with Prostate Cancer Risk. Cancer Research. 69(1). 10–15. 79 indexed citations
17.
Cramer, Scott D., Jielin Sun, S. Lilly Zheng, Jianfeng Xu, & Donna M. Peehl. (2008). Association of Prostate-Specific Antigen Promoter Genotype with Clinical and Histopathologic Features of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 17(9). 2451–2457. 14 indexed citations
18.
Wiklund, Fredrik, S. Lilly Zheng, Jielin Sun, et al.. (2008). Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. The Prostate. 69(4). 419–427. 27 indexed citations
19.
Sun, Jishan, Wennuan Liu, Tamara S. Adams, et al.. (2007). DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies. The Prostate. 67(7). 692–700. 111 indexed citations
20.
Zheng, S. Lilly, Bao-Li Chang, Jielin Sun, et al.. (2006). Germ-Line Mutation of NKX3.1 Cosegregates with Hereditary Prostate Cancer and Alters the Homeodomain Structure and Function. Cancer Research. 66(1). 69–77. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Lilly Zheng Breakdown of academic impact, for papers by Aubrey R. Turner Breakdown of academic impact, for papers by Siqun L. Zheng Breakdown of academic impact, for papers by Bao‐Li Chang Breakdown of academic impact, for papers by Kimmo Savinainen Breakdown of academic impact, for papers by Kathleen C. Torkko Breakdown of academic impact, for papers by Tuomas Mirtti Breakdown of academic impact, for papers by Andrew Strahs Breakdown of academic impact, for papers by Toshiyuki Kamoto Breakdown of academic impact, for papers by Koustubh Ranade
Rankless by CCL
2026